Remdesivir close to EU's initial authorisation as COVID-19 treatment
Published
The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
Full Article